Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
InChiKey: CMSMOCZEIVJLDB-UHFFFAOYSA-N
Saracatinib
4-triazol-1-yl)-1H-pyrrolo[2
20% SBE-β-CD in saline: Guidelines (Following is our recommended protocol
This selectivity profile
SU14813 maleate - CAS# 849643-15-8 Size:Solid 10 mg InChiKey: CMSMOCZEIVJLDB-UHFFFAOYSA-NSU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet derived growth factor receptors (PDGFR), KIT, and fms like tyrosine kinase 3 (FLT 3) (1). SU14813 was developed as a next generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity
US$ 45.00
US$ 50.00
US$ 176.00
US$ 2096.00
US$ 101.00
US$ 55.00
US$ 6750.00
Sold : Login>>